Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets.

Full prescribing information is available on request or alternatively please go to www.clonmel-health.ie. Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/356/1-3. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: July 2023. 2023/ADV/RAN/154H.

Clonmel Healthcare is delighted to announce the launch of Ranolazine Clonmel 375mg, 500mg and 750mg prolonged-release tablets

BOOTS IRELAND LAUNCHES NEW LIVER SCANNING SERVICE

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Genetic Testing Service Set to Revolutionise Prescription Medicine Launches in Ireland

Clonmel Healthcare delivers over 200 free health checks at the Clonmel Show

RCSI opens next-generation laboratories to power the future of pharmacy and biomolecular sciences

Mater Private Network announces €5.6 million investment in innovative cancer care technology

RECOMMENDED NEWS

Boots Ireland announces the opening of new store in Terminal 2, Dublin Airport

Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications

Community Pharmacy Management of Acute Pain

68% OF PEOPLE BELIEVE COVID-19 PANDEMIC HAS MADE IRISH SOCIETY RETHINK THE WAY IT DEALS WITH DEATH AND BEREAVEMENT

Quick links

Other info